Role of Neoadjuvant Targeted Therapies Remains Unclear in NSCLC

By News Health
15 hours Ago

(MedPage Today) — Use of neoadjuvant or perioperative immunotherapy in combination with chemotherapy has proven effective for some patients with non-small cell lung cancer (NSCLC), but its role in patients with EGFR- or ALK-mutated disease is…

Source link : https://www.medpagetoday.com/spotlight/asco-nsclc/116781

Author :

Publish date : 2025-08-01 14:21:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Major Medical Groups Pushed Out of Role Supporting CDC's Vaccine Advisors

'It's Gonna Be (Ly)me': Justin Timberlake Brings Attention, Awareness to Disease

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

Time Your Meals, Tune Your Metabolism

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval